Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Toxicology ; 337: 47-57, 2015 Nov 04.
Artigo em Inglês | MEDLINE | ID: mdl-26318284

RESUMO

The ubiquitin-proteasome system (UPS) is a specific, non-lysosomal pathway responsible for the controlled degradation of abnormal and short-half-life proteins. Despite its relevance in cell homeostasis, information regarding control of the UPS component gene expression is lacking. Data from a recent study suggest that the aryl hydrocarbon receptor (AHR), a ligand-dependent transcription factor, might control the expression of several genes encoding for UPS proteins. Here, we showed that activation of AHR by TCDD and ß-naphthoflavone (ß-NF) results in Ubcm4 gene induction accompanied by an increase in protein levels. UbcM4 is an ubiquitin-conjugating enzyme or E2 protein that in association with ubiquitin ligase enzymes or E3 ligases promotes the ubiquitination and 26S proteasome-mediated degradation of different proteins, including p53, c-Myc, and c-Fos. We also present data demonstrating increased c-Fos ubiquitination and proteasomal degradation through the AHR-mediated induction of UbcM4 expression. The present study shows that AHR modulates the degradation of proteins involved in cell cycle control, consistent with previous reports demonstrating an essential role of the AHR in cell cycle regulation.


Assuntos
Complexo de Endopeptidases do Proteassoma/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-fos/metabolismo , Receptores de Hidrocarboneto Arílico/efeitos dos fármacos , Enzimas de Conjugação de Ubiquitina/biossíntese , Ubiquitinação/efeitos dos fármacos , Linhagem Celular , Expressão Gênica/efeitos dos fármacos , Técnicas de Silenciamento de Genes , Humanos , Plasmídeos/efeitos dos fármacos , Dibenzodioxinas Policloradas/farmacologia , Proteínas Proto-Oncogênicas c-fos/efeitos dos fármacos , Transfecção , Enzimas de Conjugação de Ubiquitina/efeitos dos fármacos , Enzimas de Conjugação de Ubiquitina/genética , beta-Naftoflavona/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA